🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

30 recruiting trials

for Drug Dose

A Study to Learn How Different Amounts of the Study Medicine Called PF-08065010 Are Tolerated and Act in the Body of Healthy Adults NCT07235163Phase 11 site📍 Brussels Pfizer · Tests: PF-08065010, Placebo Low-dose NOAC Versus GDMT After LAAO NCT05960721NA1 site📍 Xi'an Xijing Hospital · Tests: Rivaroxaban 15mg, Aspirin 100mg, Clopidogrel 75mg, Rivaroxaban 10mg, Rivaroxaban 2.5mg An Experimental Medicine Multicenter Trial to Evaluate the Safety and Immunogenicity of Experimental Versus Authorized SARS-CoV-2 Vaccine Candidates as a Booster Dose in Healthy Participants Previously Vaccinated With Authorized mRNA SARS-CoV-2 Vaccines. NCT07605520EARLY Phase 13 sites📍 Créteil📍 Paris📍 Lausanne ANRS, Emerging Infectious Diseases · Tests: CD40.RBDv vaccine adjuvanted with Hiltonol®, CD40.Pan.CoV vaccine adjuvanted with Hiltonol®, Comirnaty® vaccine, Nuvaxo… A Study of NHL907 in Healthy Adult Participants NCT07580924Phase 11 site📍 Adelaide NeuHyll AUS Pty Ltd · Tests: NHL907, Placebo A Study to Learn About How Different Forms of Study Medicine Prifetrastat Are Taken Up Into the Blood in Healthy Adults NCT07721402Phase 11 site📍 Brussels Pfizer · Tests: prifetrastat Reference, prifetrastat Test 1, prifetrastat Test 2 Aroxxen® Inhalation for Cardioprotection After Elective PCI With Stent Implantation NCT07397351Phase 21 site📍 Saint Petersburg Research Institute of Geroprotective Technologies · Tests: Aroxxen GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer NCT07489287Phase 11 site📍 Buffalo Roswell Park Cancer Institute · Tests: GB-5267 - IV only, GB-5267 -Combined IV and IP Infusion A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors NCT07814248Phase 13 sites📍 Maumee📍 Portland📍 Fairfax TwoStep Therapeutics, Inc. · Tests: TS-104 High-dose Chemotherapy as Second-line Drug Therapy for Relapsed Germ Cell Tumors NCT06418789Phase 21 site📍 Saint Petersburg N.N. Petrov National Medical Research Center of Oncology · Tests: High-dose chemotherapy (TI- 2 cycles, CE- 3 cycles ) Abuse Potential of Gabapentin Taken Orally Concomitantly With Oxycodone Hydrochloride in Healthy, Non-Drug-Dependent, Recreational Opioid Users NCT07813026Phase 41 site📍 Overland Park Viatris Inc. · Tests: Placebo, Oxycodone 20mg, gabapentin 600 mg, Gabapentin 1200mg, Gabapentin 600 mg + Oxycodone 20 mg A Phase 2a, Single-dose, Open-label Study to Evaluate Diagnostic Performance and Safety of Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Cancer, in Patients With Unknown Primary Head and Neck Cancer (ILLUMINATE STUDY) NCT05576974Phase 21 site📍 Dallas University of Texas Southwestern Medical Center · Tests: Pegsitacianine A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors NCT06440005Phase 17 sites📍 Los Angeles📍 Sarasota📍 St Louis Angiex, Inc. · Tests: AGX101 Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1) NCT05862012Phase 132 sites📍 Palo Alto📍 Miami📍 Atlanta Ichnos Sciences SA · Tests: ISB 2001, ISB 2001 Study of Olatorepatide in Adult Participants Living With Overweight or Obesity Without Diabetes NCT07685808Phase 221 sites📍 Mobile📍 Walnut Creek📍 Waterbury Regeneron Pharmaceuticals · Tests: Olatorepatide, Placebo Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease NCT03844360Phase 42 sites📍 Xuzhou📍 Tanjin Wei Zhao · Tests: Bortezomib, Eltrombopag, Imatinib, dasatinib, Pegaspargase Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors NCT07145255Phase 1, Phase 27 sites📍 San Francisco📍 Grand Rapids📍 East Brunswick MBrace Therapeutics · Tests: ADC Comparison of Vedolizumab Treatment to Adalimumab Dose Intensification in Crohn's Disease Patients With Loss of Response or Biomarker Activity to Adalimumab on First Line With Therapeutic Drug Concentration. NCT06180382Phase 412 sites📍 Le Kremlin-Bicêtre📍 Amiens📍 Lille Centre Hospitalier Universitaire de Saint Etienne · Tests: Adalimumab, Vedolizumab Single Dose of Antenatal Corticosteroids for Pregnancies at Risk of Preterm Delivery (SNACS) NCT05114096Phase 425 sites📍 Calgary📍 Edmonton📍 New Westminster McMaster University · Tests: Celestone + placebo, Celestone + Celestone A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity NCT07395687Phase 23 sites📍 Cypress📍 Overland Park📍 Montreal Novo Nordisk A/S · Tests: UBT251, Placebo Comparison of DW-1021 and Separate Doses of Pelubi CR and Zytram CR Under Fasting Conditions NCT07032558Phase 12 sites📍 Haiphong📍 Haiphong Haiphong University of Medicine and Pharmacy · Tests: DW-1021, Pelubi CR + Zytram CR A Randomized, Open-label, Two-arm, Two-period, Multiple-dose, Study to Evaluate Pharmacokinetic Drug-drug Interaction, Safety and Tolerability of UIC202601 and UIC202602 in Healthy Volunteers NCT07682948Phase 11 site📍 Anyang Korea United Pharm. Inc. · Tests: Investigational Product 1, Investigational Product 2, Investigational Product 1 + Investigational Product 2 A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites📍 Grand Rapids📍 St Louis📍 Pittsburgh AstraZeneca · Tests: AZD6750, rilvegostomig A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors NCT06747585Phase 1, Phase 241 sites📍 Scottsdale📍 Fullerton📍 Los Angeles Alentis Therapeutics AG · Tests: ALE.P02, Pembrolizumab Drug-induced Crystalluria in Sulfamethoxazole, High Dose Ciprofloxacin and High Dose Amoxicillin NCT07772752NA1 site📍 Brussels Universitair Ziekenhuis Brussel · Tests: Crystalluria examination A Study to Investigate the Safety and Tolerability of Oral INR731 Single Agent or in Combination With Androgen Receptor Pathway Inhibitor (ARPI) in Patients With Metastatic Prostate Cancer NCT07570979Phase 113 sites📍 Boston📍 Dallas📍 Melbourne Novartis Pharmaceuticals · Tests: INR731, Enzalutamide, Abiraterone, Androgen deprivation therapy (ADT) A Study to See How Safe a New Medicine (NNC6989-0001) is in Healthy People Living With Overweight or Obesity NCT07437079Phase 11 site📍 Lenexa Novo Nordisk A/S · Tests: NNC6989-0001, Placebo (NNC6989-0001) Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma NCT07377045Phase 17 sites📍 Boston📍 Barcelona📍 Donostia / San Sebastian Oncomatryx Biopharma S.L. · Tests: OMTX705, Nab-paclitaxel + Gemcitabine, Tislelizumab (i.v. 200mg) Dose Escalation and Expansion Study of BH3120 Alone or With Pembrolizuamb in Advanced or Metastatic Solid Tumors NCT06234397Phase 110 sites📍 Tampa📍 Grand Rapids📍 Cincinnati Hanmi Pharmaceutical Company Limited · Tests: BH3120, pembrolizumab Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM) NCT06562907Phase 13 sites📍 Miami📍 San Antonio📍 Salt Lake City Gilead Sciences · Tests: GS-4571, Placebo, Omeprazole Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery NCT07164300NA1 site📍 Ioannina University of Ioannina · Tests: Tranexamic acid at a dose of 10 mg/kg followed by 1 mg/kg/h, Tranexamic acid at a dose of 20 mg/kg, Tranexamic acid at …
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy